MBX
MBX BiosciencesFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
MBX vs peer average
15/100
MBX vs. peer average (F vs. B)
Grade spread
A 3 · B 3 · C 3 · D 1 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
CRSP is the first available peer comparator.
Large-cap gene‑editing peer; useful qualitative comparison for pipeline commercialization and partnership dynamics.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
MBX
MBX Biosciences
CRSP
CRISPR Therapeutics
Grade
F
B
Momentum
29
25
Value
41
41
Sentiment
29
78
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs CRSP
MBX / CRSP
Grade Position
Below peers
MBX vs. peer average (F vs. B)
15/100
Momentum
29
MBXValue
41
MBXSentiment
29
CRSPRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs MBX
CRSP is the first peer returned for this comparison set.